Diminishing Returns of Novel Autoantibody Discovery in Encephalitis
This Viewpoint describes a plateau in the discovery of clinically meaningful autoantibodies in autoimmune encephalitis (AE) and suggests efforts that are likely to offer greater benefits to patients living with AE.
Authors
- Frank Leypoldt (ORCID: https://orcid.org/0000-0002-8972-515X)
- Sarosh R. Irani (ORCID: https://orcid.org/0000-0002-7667-9748)
- Naoki Takegami
- Gregory S. Day
Institutions
- Jacksonville College (US)
- University of Oxford (GB)
- University Hospital Schleswig-Holstein (DE)
- Mayo Clinic in Florida (US)
- University of Lübeck (DE)
Publication Details
- Journal
- JAMA Neurology
- Published
- 2026-06-29
- DOI
- https://doi.org/10.1001/jamaneurol.2026.1659
- Primary Topic
- Autoimmune Neurological Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00